United Kingdom

Ludwig Burger

Jeff Mason is a White House Correspondent for Reuters and the 2016-2017 president of the White House Correspondents’ Association. He was the lead Reuters correspondent for President Barack Obama's 2012 campaign and interviewed the president at the White House in 2015. Jeff has been based in Washington since 2008, when he covered the historic race between Obama, Hillary Clinton and John McCain. Jeff started his career in Frankfurt, Germany, where he covered the airline industry before moving to Brussels, Belgium, where he covered the European Union. He is a Colorado native, proud graduate of Northwestern University and former Fulbright scholar.

Twitter handle: @jeffmason1

16 Mar 2018

Siemens Healthineers up 7 percent on 4.2 billion euro market debut

FRANKFURT Shares in Siemens Healthineers gained as much as 7 percent in the medical equipment maker's stock market debut on Friday, boding well for a string of pending German flotations including asset manager DWS. | Video

07 Mar 2018

Siemens' Healthineers share listing fully subscribed: bookrunner

MUNICH/FRANKFURT German engineering group Siemens has attracted demand for all shares on offer in the initial public offering of its medical imaging and diagnostics business, one of the bookrunners leading the transaction said on Wednesday.

07 Mar 2018

Bayer in exclusive talks to sell vegetable seeds business to BASF

FRANKFURT Bayer has entered exclusive talks with BASF on the sale of its Nunhems vegetable seeds unit to address antitrust regulators' concerns over its planned merger with Monsanto , the two companies said.

02 Mar 2018

DSM launches sale of anti-infectives maker DSP - sources

FRANKFURT, March 2 Dutch speciality chemicals company DSM has launched the sale of its anti-infectives unit DSM Sinochem Pharmaceuticals (DSP), a potential 640 million euro ($785 million) deal, as it seeks to streamline its portfolio, people close to the matter said.

28 Feb 2018

Bayer goes through 'ups and downs' as Monsanto deal drags on

LEVERKUSEN, Germany Bayer on Wednesday said it would need more time to wrap up its takeover of seeds company Monsanto after the drugmaker reported lower than expected fourth-quarter earnings which were hit by pesticide pricing pressures in Brazil.

27 Feb 2018

BASF expects profit gain on specialty chemicals rebound

LUDWIGSHAFEN, Germany Germany's BASF said it was aiming for a gain of up to 10 percent in group operating profit this year as it bets on a rebound in specialty chemicals to offset an expected weaker performance in basic petrochemicals.

15 Feb 2018

Merck KGaA, Pfizer's immunotherapy fails in lung cancer trial

FRANKFURT Merck KGaA and Pfizer received a setback on Thursday for their drug Bavencio, which is a late starter in the rapidly evolving field of cancer immunotherapies.

13 Feb 2018

Bayer petitions Russian antitrust watchdog for more time in Monsanto case

FRANKFURT/MOSCOW Bayer has taken Russia's antitrust regulator to court over the watchdog's investigation into the company's planned takeover of Monsanto , a further hiccup in the $64 billion deal amid intense antitrust scrutiny.

06 Feb 2018

Linde expects bigger antitrust hurdle for Praxair merger

FRANKFURT German industrial gases maker Linde said on Tuesday it expected it would have to make more divestments than initially planned to win antitrust approval for its $84 billion merger with Praxair .

05 Feb 2018

Bayer offers to sell businesses to win EU approval for Monsanto deal

BRUSSELS/FRANKFURT Bayer has offered to sell seeds and pesticides businesses to try to address EU competition concerns over its $63.5 billion (£45.3 billion) bid for U.S. rival Monsanto.

  • Europe
  • U.S.
  • Asia
  • Sectors
Stock Search
FTSE 100 7,005.54 -33.43 -0.47%
DAX 12,188.60 -120.55 -0.98%
CAC 40 5,185.19 -54.55 -1.04%
TR Europe 185.71 -1.10 -0.59%
GBP/USD 1.4167 +0.20%
GBP/EUR 1.1453 -0.04%
EUR/USD 1.2366 +0.24%
Gold 1,320.70 +0.00 +0.00%
Oil 64.68 -0.49 -0.75%
Corn 377.25 +2.25 +0.60%